Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 5/20 | 0.37 |
| ▸ | ACACB | O00763 | 6/20 | 0.34 |
| ▸ | CNR2 | P34972 | 7/20 | 0.33 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.33 |
| ▸ | FEN1 | P39748 | 1/20 | 0.33 |
| ▸ | CNR1 | P21554 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12223926 | 1.00 | GPR119 (0.37) | GPR119ACACBCNR2ALOX5APFEN1 | |
| SCHEMBL11939324 | 0.93 | CNR2 (0.37) | CNR2ALOX5APFEN1CNR1 | |
| SCHEMBL11939352 | 0.93 | CNR2 (0.37) | CNR2ALOX5APFEN1CNR1 | |
| SCHEMBL14922575 | 0.90 | GPR119 (0.37) | GPR119ACACBALOX5APFEN1 | |
| SCHEMBL11939217 | 0.90 | FPR2 (0.36) | ACACBALOX5APFEN1 | |
| SCHEMBL14922638 | 0.90 | GPR119 (0.37) | GPR119ACACBALOX5APFEN1 | |
| SCHEMBL12223974 | 0.89 | FPR2 (0.33) | ACACBCNR2ALOX5APFEN1CNR1 | |
| SCHEMBL12223510 | 0.89 | GPR119 (0.34) | GPR119ACACBCNR2ALOX5APFEN1 | |
| SCHEMBL12223321 | 0.89 | GPR119 (0.34) | GPR119ACACBCNR2ALOX5APFEN1 | |
| SCHEMBL12223501 | 0.88 | CNR2 (0.40) | CNR2ALOX5APFEN1CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110240919-A1 | FIVE-RING COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | CHISSO CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110240919-A1 | FIVE-RING COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | NCAPD3, CCND3, ZKSCAN2 | GPR119 4269/4885ACACB 2691/4885CNR2 253/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.